Food and Drug Administration

Drag Safety and Risk Management Advisory Committee

September 19, 2003

Briefing Information

Screening Methods to Assess Sound Alike and Look Alike Proprietary Drug Names

Welcome Letter, Dr. Victor Raczkowski, MD, FDA (HTM )(PDF)

Table of Contents (HTM) (PDF) (Word)

Executive Summary (HTM) (PDF) (Word)

Letter Regarding Docket Number 02N-0201; Minimizing Medication Errors - Methods for Evaluating Proprietary Names for Their Confusion Potential; Public Meeting, Scott Lassman, PhRMA (PDF)

Evaluating Drug Names for Similarities: Methods and Approaches Public Meeting (PDF)

Trademark Evaluation Process: An Industry Perspective, Sharon Olmstead, Pfizer (HTM) (PPT)

Proprietary Name Testing Using "Prescription Analysis Studies", Thomas Hassall, MS, Merck Research Laboratories (HTM) (PPT)

Tradmark Development (PDF)

Look-Alike and Sound-Alike Medications - Practitioner Perspectives, Dr. Timothy Lesar, PhrmD, Albany Medical Ctr.(HTM) (PPT)

Proprietary Names and the Drug Approval Process, Dr. John Jenkins, MD, FCCP, FDA (HTM) (PPT)

Current Practices for Data Collection & Decision Analysis, Robert Lee, Jr. (HTM) (PPT)

Evaluating Drug Names for Similarities: Techniques and Methods to Collect Data and Make Decisions, Brand Institute, Inc. (PDF)

DMETS Evaluation of Proprietary Names, Jerry Phillips, RPh, FDA (HTM) (PPT)

Evaluating Names for Similarities: Methods and Approaches - Public Meeting, Interbrand Wood Healthcare (HTM) (PPT)

Medical Error, Dr. Brian Strom, MD, MPH, University of Pennsylvania (HTM) (PPT)

Screening Proprietary Drug Names for Similarities: Research Design and Questionnaire Structure, Dr. Shari Diamond, JD, PhD, Northwest Univeristy (HTM) (PPT)

Evaluating Drug Names Similarities Applying Handwriting Recognition Technologies, Kaz Jaszczak, Parascript, LLC (PDF)

Expert Committees, Dr. R. Shangraw, Jr., PhD, Project Performance Corp. (HTM) (PPT)

Computational Linguistic Techniques Applied to Drugname Matching, Bonnie Dorr, University of MD and Greg Kondrak, University of Alberta (HTM) (PPT)

Computer Assisted Decision Analysis in Drug Naming, Dr. Bruce Lambert, PhD, University of Illinois (PDF)

Screening for Drug Similarities With Human Factors Engineering & Failure Mode and Effects Analysis, Dr. John Gosbee, MD, MS, VA Nat'l Ctr. for Patient Safety (PDF)

Evaluating Drug Names for Similarities: Methods and Approaches Public Meeting, Dr. Bill Campbell, PhD, CERTs (HTM) (PPT)

Bibliography (HTM) (PDF) (Word)

Medication Errors, FDA (PDF)